Molecular Signatures in Prion Disease: Altered Death Receptor Pathways in a Mouse Model

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2024 May 27

PMID 38802941

Authors

Ranjit Kumar Giri

Affiliations

Soon will be listed here.

Abstract

Background: Prion diseases are transmissible and fatal neurodegenerative diseases characterized by accumulation of misfolded prion protein isoform (PrP), astrocytosis, microgliosis, spongiosis, and neurodegeneration. Elevated levels of cell membrane associated PrP protein and inflammatory cytokines hint towards the activation of death receptor (DR) pathway/s in prion diseases. Activation of DRs regulate, either cell survival or apoptosis, autophagy and necroptosis based on the adaptors they interact. Very little is known about the DR pathways activation in prion disease. DR3 and DR5 that are expressed in normal mouse brain were never studied in prion disease, so also their ligands and any DR adaptors. This research gap is notable and investigated in the present study.

Methods: C57BL/6J mice were infected with Rocky Mountain Laboratory scrapie mouse prion strain. The progression of prion disease was examined by observing morphological and behavioural abnormalities. The levels of PrP isoforms and GFAP were measured as the marker of PrP accumulation and astrocytosis respectively using antibody-based techniques that detect proteins on blot and brain section. The levels of DRs, their glycosylation and ectodomain shedding, and associated factors warrant their examination at protein level, hence western blot analysis was employed in this study.

Results: Prion-infected mice developed motor deficits and neuropathology like PrP accumulation and astrocytosis similar to other prion diseases. Results from this research show higher expression of all DR ligands, TNFR1, Fas and p75NTR but decreased levels DR3 and DR5. The levels of DR adaptor proteins like TRADD and TRAF2 (primarily regulate pro-survival pathways) are reduced. FADD, which primarily regulate cell death, its level remains unchanged. RIPK1, which regulate pro-survival, apoptosis and necroptosis, its expression and proteolysis (inhibits necroptosis but activates apoptosis) are increased.

Conclusions: The findings from the present study provide evidence towards the involvement of DR3, DR5, DR6, TL1A, TRAIL, TRADD, TRAF2, FADD and RIPK1 for the first time in prion diseases. The knowledge obtained from this research discuss the possible impacts of these 16 differentially expressed DR factors on our understanding towards the multifaceted neuropathology of prion diseases and towards future explorations into potential targeted therapeutic interventions for prion disease specific neuropathology.

References

Yagita H, Takeda K, Hayakawa Y, Smyth M, Okumura K . TRAIL and its receptors as targets for cancer therapy. Cancer Sci. 2004; 95(10):777-83. PMC: 11159975. DOI: 10.1111/j.1349-7006.2004.tb02181.x. View

Klima M, Zajedova J, Doubravska L, Andera L . Functional analysis of the posttranslational modifications of the death receptor 6. Biochim Biophys Acta. 2009; 1793(10):1579-87. DOI: 10.1016/j.bbamcr.2009.07.008. View

Campbell I, Eddleston M, Kemper P, Oldstone M, Hobbs M . Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol. 1994; 68(4):2383-7. PMC: 236715. DOI: 10.1128/JVI.68.4.2383-2387.1994. View

Migone T, Zhang J, Luo X, Zhuang L, Chen C, Hu B . TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002; 16(3):479-92. DOI: 10.1016/s1074-7613(02)00283-2. View

Stoeck K, Bodemer M, Zerr I . Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol. 2005; 172(1-2):175-81. DOI: 10.1016/j.jneuroim.2005.10.008. View

Bartsch J, Wildeboer D, Koller G, Naus S, Rittger A, Moss M . Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection. J Neurosci. 2010; 30(36):12210-8. PMC: 6633558. DOI: 10.1523/JNEUROSCI.1520-10.2010. View

Mammadova N, Greenlee M, Moore S, Sakaguchi D, Greenlee J . Experimental Study Using Multiple Strains of Prion Disease in Cattle Reveals an Inverse Relationship between Incubation Time and Misfolded Prion Accumulation, Neuroinflammation, and Autophagy. Am J Pathol. 2020; 190(7):1461-1473. DOI: 10.1016/j.ajpath.2020.03.006. View

Hu Y, Lee X, Shao Z, Apicco D, Huang G, Gong B . A DR6/p75(NTR) complex is responsible for β-amyloid-induced cortical neuron death. Cell Death Dis. 2013; 4:e579. PMC: 3641333. DOI: 10.1038/cddis.2013.110. View

Cunningham C, Boche D, Perry V . Transforming growth factor beta1, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix. Neuropathol Appl Neurobiol. 2002; 28(2):107-19. DOI: 10.1046/j.1365-2990.2002.00383.x. View

10.

Peter M, Krammer P . The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003; 10(1):26-35. DOI: 10.1038/sj.cdd.4401186. View

11.

Pobezinskaya Y, Kim Y, Choksi S, Morgan M, Li T, Liu C . The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. Nat Immunol. 2008; 9(9):1047-54. PMC: 2577920. DOI: 10.1038/ni.1639. View

12.

Ma Y, Shi Q, Xiao K, Wang J, Chen C, Gao L . Stimulations of the Culture Medium of Activated Microglia and TNF-Alpha on a Scrapie-Infected Cell Line Decrease the Cell Viability and Induce Marked Necroptosis That Also Occurs in the Brains from the Patients of Human Prion Diseases. ACS Chem Neurosci. 2018; 10(3):1273-1283. DOI: 10.1021/acschemneuro.8b00354. View

13.

Boatright K, Salvesen G . Mechanisms of caspase activation. Curr Opin Cell Biol. 2003; 15(6):725-31. DOI: 10.1016/j.ceb.2003.10.009. View

14.

Chhibber-Goel J, Coleman-Vaughan C, Agrawal V, Sawhney N, Hickey E, Powell J . γ-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling. J Biol Chem. 2016; 291(11):5971-5985. PMC: 4786730. DOI: 10.1074/jbc.M115.679076. View

15.

Newton K . Multitasking Kinase RIPK1 Regulates Cell Death and Inflammation. Cold Spring Harb Perspect Biol. 2019; 12(3). PMC: 7050590. DOI: 10.1101/cshperspect.a036368. View

16.

Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A . PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med. 2013; 19(9):1124-31. DOI: 10.1038/nm.3302. View

17.

Hsu H, Shu H, Pan M, Goeddel D . TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996; 84(2):299-308. DOI: 10.1016/s0092-8674(00)80984-8. View

18.

Mastrianni J, Nixon R, Layzer R, Telling G, Han D, DeArmond S . Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med. 1999; 340(21):1630-8. DOI: 10.1056/NEJM199905273402104. View

19.

CHANDLER R . Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet. 1961; 1(7191):1378-9. DOI: 10.1016/s0140-6736(61)92008-6. View

20.

Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y . Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 1996; 379(6563):339-43. DOI: 10.1038/379339a0. View